Moderate-intensity exercise may have benefits for mitochondrial myopathies
Moderate exercise may be both safe and beneficial for people with mitochondrial myopathy, a group of rare muscle diseases that includes TK2d.
All articles by Clarissa Brincat
-
-
Review explores care for tracheostomy-associated infections in children
New research is changing the way doctors diagnose, treat and prevent respiratory infections in children with tracheostomies.
-
New tests improving diagnosis and monitoring of mitochondrial diseases
New blood tests, wearable devices and advanced brain scans are improving the ability to diagnose and monitor primary mitochondrial diseases.
-
Study identifies the most common G-tube problems
A recent study examined problems related to gastrostomy tubes (G-tubes), a type of feeding tube used by many patients with TK2d.
-
New framework to diagnose and treat mitochondrial diseases
A recent study provides a better way to understand and classify primary mitochondrial disorders, such as thymidine kinase 2 deficiency (TK2d).
-
Global study aims to improve research on mitochondrial disease
mitoSHARE is working to improve research on mitochondrial disease by collecting real-life health information from patients around the world.
-
Progress in testing and treatment brings hope for muscle diseases like TK2d
New genetic tests and targeted treatments are improving diagnosis and care for muscle diseases like thymidine kinase 2 deficiency (TK2d).
-
Mitochondrial diseases may be linked to sleep disorders
Patients with a mitochondrial disease called MELAS syndrome were found to have a high rate of obstructive sleep apnea and poor sleep quality.
-
First treatment for TK2d may soon be approved in Europe
The European Medicines Agency (EMA) has recommended approving Kygevvi (doxecitine and doxribtimine) for use in the European Union.
-
Study: Patients treated with Kygevvi saw a reduced risk of death
Patients who received a newly-approved drug for TK2d had much lower rates of death than patients who were not.
